---
title: "Aurora Cannabis Inc. (ACB.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ACB.US.md"
symbol: "ACB.US"
name: "Aurora Cannabis Inc."
industry: "Pharmaceuticals"
datetime: "2026-03-14T05:16:19.786Z"
locales:
  - [en](https://longbridge.com/en/quote/ACB.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACB.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACB.US.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ACB.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ACB.US.md)


# Aurora Cannabis Inc. (ACB.US)

## Company Overview

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.auroramj.com](https://www.auroramj.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-03-13T04:30:15.000Z

**Overall: C (0.48)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 82 / 188 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.58% |  |
| Net Profit YoY | -30838.96% |  |
| P/B Ratio | 0.51 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 199030281.84 |  |
| Revenue | 166168258.47 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -15.06% | E |
| Profit Margin | -22.51% | E |
| Gross Margin | 49.50% | B |
| Revenue YoY | 15.58% | B |
| Net Profit YoY | -30838.96% | E |
| Total Assets YoY | -6.23% | D |
| Net Assets YoY | -2.82% | D |
| Cash Flow Margin | -27.54% | D |
| OCF YoY | 15.58% | B |
| Turnover | 0.45 | C |
| Gearing Ratio | 26.76% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Aurora Cannabis Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.58%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-30838.96%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.51",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "199030281.84",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "166168258.47",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-15.06%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-22.51%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "49.50%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "15.58%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-30838.96%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-6.23%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.82%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-27.54%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "15.58%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.45",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "26.76%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.21 | 146/188 | 155.41 | 80.79 | 66.65 |
| PB | 0.50 | 21/188 | 0.73 | 0.65 | 0.60 |
| PS (TTM) | 0.72 | 27/188 | 1.17 | 1.04 | 0.92 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Eli Lilly (LLY.US) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | C | B |
| 03 | Roche (RHHBY.US) | A | B | B | D | C | B |
| 04 | AstraZeneca (AZN.US) | A | B | C | D | C | B |
| 05 | NOVARTIS AG (NVS.US) | A | B | C | D | C | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-06T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 60% |
| Hold | 2 | 40% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.43 |
| Highest Target | 6.34 |
| Lowest Target | 6.34 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ACB.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ACB.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ACB.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ACB.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**